Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir vs Tenofovir + Emtricitabine in Chronic Hepatitis B
NCT00524173Phase 2Terminated
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Aug 2007
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tenofovir disoproxil fumarate, emtricitabine in hepatitis B (HBV), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Aug 2007; status: terminated.
02
Drugs
tenofovir disoproxil fumarateemtricitabine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00524173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524173.